SCHEMBL25012912

SCHEMBL25012912

CCC(CC)COC(=O)[C@H](C)NP(=O)(OC[C@@H]1CCC(C#N)(c2ccc3c(N)ncnn23)O1)Oc1ccc2ccccc2c1

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CSNK1A1 P48729 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24148708 0.93 CYP3A4 (0.32) —
SCHEMBL18636608 0.93 CYP3A4 (0.32) —
SCHEMBL25012546 0.90 — —
SCHEMBL22096277 0.87 AXL (0.30) —
SCHEMBL24148688 0.86 TMPRSS2 (0.38) —
SCHEMBL30269887 0.86 TMPRSS2 (0.38) —
SCHEMBL24149678 0.84 DOT1L (0.31) —
SCHEMBL21284180 0.83 CYP3A4 (0.35) —
SCHEMBL10154202 0.83 CYP3A4 (0.35) —
SCHEMBL24149494 0.83 TMPRSS2 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040586-A1 1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF GILEAD SCIENCES, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040586-A1 1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF TYMP, PNP, DUT CSNK1A1 1683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback